Literature DB >> 33652918

Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization.

Nisha Asok Kumar1,2, Sreenath Muraleedharan Suma1, Umerali Kunnakkadan1,3, Joydeep Nag1,2, Reshma Koolaparambil Mukesh1,2, Douglas S Lyles4, John Bernet Johnson1.   

Abstract

The human complement system is an important part of the innate immune system. Its effector pathways largely mediate virus neutralization. Vesicular stomatitis virus (VSV) activates the classical pathway of the complement, leading to virus neutralization by lysis. Two host-derived membrane-associated regulators of complement activation (RCA), CD55 and CD46, which are incorporated into the VSV envelope during egress, confer protection by delaying/resisting complement-mediated neutralization. We showed previously that CD55 is more effective than CD46 in the inhibition of neutralization. In this study, we identified that, at the protein level, VSV infection resulted in the down-regulation of CD46 but not CD55. The mRNA of both the RCAs was significantly down-regulated by VSV, but it was delayed in the case of CD55. The immunoblot analysis of the levels of RCAs in the progeny virion harvested at three specific time intervals, points to an equal ratio of its distribution relative to viral proteins. Besides reconfirming the dominant role of CD55 over CD46 in shielding VSV from complement, our results also highlight the importance of the subtle modulation in the expression pattern of RCAs in a system naturally expressing them.

Entities:  

Keywords:  complement; decay accelerating factor (CD55); membrane cofactor protein (CD46); vesicular stomatitis virus; viral resistance; virus neutralization

Year:  2021        PMID: 33652918      PMCID: PMC7996768          DOI: 10.3390/v13030373

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  50 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  Defining the role of CD46, CD80 and CD86 in mediating adenovirus type 3 fiber interactions with host cells.

Authors:  Kathryn Hall; Maria E Blair Zajdel; G Eric Blair
Journal:  Virology       Date:  2009-08-13       Impact factor: 3.616

3.  Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor.

Authors:  Fumihiko Osuka; Yuichi Endo; Mitsunori Higuchi; Hiroyuki Suzuki; Yutaka Shio; Koichi Fujiu; Ryuzo Kanno; Akio Oishi; Masanori Terashima; Teizo Fujita; Mitsukazu Gotoh
Journal:  Genomics       Date:  2006-02-28       Impact factor: 5.736

Review 4.  Membrane complement regulatory proteins.

Authors:  David D Kim; Wen-Chao Song
Journal:  Clin Immunol       Date:  2005-12-09       Impact factor: 3.969

5.  Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing.

Authors:  S M Russell; R L Sparrow; I F McKenzie; D F Purcell
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

6.  Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.

Authors:  Yujia Li; John B Johnson; Griffith D Parks
Journal:  Virology       Date:  2016-08-06       Impact factor: 3.616

7.  Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo.

Authors:  B L Black; D S Lyles
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

8.  Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.

Authors:  Sina Bavari; Catharine M Bosio; Elizabeth Wiegand; Gordon Ruthel; Amy B Will; Thomas W Geisbert; Michael Hevey; Connie Schmaljohn; Alan Schmaljohn; M Javad Aman
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

9.  Group Selection and Contribution of Minority Variants during Virus Adaptation Determines Virus Fitness and Phenotype.

Authors:  Antonio V Bordería; Ofer Isakov; Gonzalo Moratorio; Rasmus Henningsson; Sonia Agüera-González; Lindsey Organtini; Nina F Gnädig; Hervé Blanc; Andrés Alcover; Susan Hafenstein; Magnus Fontes; Noam Shomron; Marco Vignuzzi
Journal:  PLoS Pathog       Date:  2015-05-05       Impact factor: 6.823

10.  DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice.

Authors:  Mitsuhiro Iyori; Daisuke S Yamamoto; Miako Sakaguchi; Masanori Mizutani; Sota Ogata; Hidesato Nishiura; Takahiko Tamura; Hiroyuki Matsuoka; Shigeto Yoshida
Journal:  Malar J       Date:  2017-09-29       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.